3,574 research outputs found
Responding to the challenge of cancer in Europe.
No full textThe term “cancer” is commonly used to cover a wide range of diseases which all share
a common feature, namely that cells in affected organs or tissues of the body (e.g. breast,
lung, skin or bone marrow) continue to grow indefinitely, without reference to the needs
of the body. Many cancers have the capacity to spread to other parts of the body and to
kill the patient. With more than 3 million new cases and 1.7 million deaths each year, cancer
currently represents the second most important cause of death and morbidity in Europe.
This volume, published under the Slovenian Presidency of the European Union, is a
review of the current status of cancer control in the European Union. The aim was to
summarize the evidence that should underpin policy for the prevention, management
and palliation of cancer in Europe.
The book has been produced as a collaborative effort between internationally recognized
public health institutes in the European Union, under the umbrella Fighting Against
Cancer Today (FACT). FACT is co-funded by the Government of Slovenia and the
European Commission’s Health and Consumer Protection Directorate, with additional
support from the European Observatory on Health Systems and Policies
2006 Spring Commencement
No full textMary Sue Coleman gives graduation remarks at Spring Commencement 2006 Remarks to Graduates University of Michigan President, Mary Sue Coleman, addresses the university community at the Spring 2006 Commencement held at Michigan Stadium.http://deepblue.lib.umich.edu/bitstream/2027.42/93444/1/MSC_QTspr06.mp
2004 Commencement Remarks
No full textUniversity of Michigan President, Mary Sue Coleman, addresses the university community at the Winter 2004 Commencement held at Michigan Stadium. Remarks to Graduates Mary Sue Coleman gives graduation remarks at Winter Commencement 2004http://deepblue.lib.umich.edu/bitstream/2027.42/93446/1/MSC_QTwin04.mp
2007 Spring Commencement
No full textUniversity of Michigan President, Mary Sue Coleman, addresses the university community at the Spring 2007 Commencement held at Michigan Stadium. Remarks to Graduates Mary Sue Coleman gives graduation remarks at Spring Commencement 2007http://deepblue.lib.umich.edu/bitstream/2027.42/93445/1/MSC_QTspr07.mp
Application of the IS-MP-IA model to the German economy and policy implications
No full textExtending the IS-MP-IA model developed by Romer (2000) and applying the GARCH (Engle, 1982, 2001) methodology, the author finds that equilibrium GDP in Germany is positively affected by stock market performance and real exchange rate appreciation, and negatively influenced by the expected inflation rate, the government deficit/GDP ratio, and the U.S. federal funds rate. The relatively low deficit/GDP ratio of 1.83% in 2003 indicates that its fiscal condition was healthy. However, some other EU members may need to exercise fiscal discipline. Because real appreciation has a positive impact on output, a stronger euro may not be a concern for Germany but may be worried by those EU member nations which depend upon exports to stimulate their economies.
Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers?
No full textOBJECTIVE: To investigate whether cancer service standards are associated with survival for breast, colorectal and lung cancers at population level. METHODS: Standards of hospital cancer services in England, measured in 2001, were aggregated for 30 cancer networks covering populations of between 500 000 and 3 million people, and compared with 1-year and 5-year relative cancer survival for the incident period 1996-2001, using rank correlation. RESULTS: Relative survival and the cancer standards each showed statistically significant differences across cancer networks. For tumour-specific services, the total score of 35 standards was associated with longer relative survival for both colorectal and lung cancers (p<0.05), but not breast cancer, while colorectal cancer survival was strongly (p<0.01) associated with the specific standard "written agreement describing referral guidelines", and lung cancer (p<0.05) with two other guideline standards. There were also associations of longer survival with two measures of nursing staff specialist qualifications. Compliance with general standards for cancer services was not associated with survival for breast cancer, and showed only borderline (p<0.1) associations for colo-rectal cancer, while some standards on medical and management lead staff were significantly associated (p<0.05) with poorer survival for lung cancer. Overall, compliance with standards for hospital pathology and radiology services also showed no associations with survival. CONCLUSION: This study suggests that compliance with some clinical service standards, such as guidelines, could contribute to better survival at population level, while more general organisational aspects of cancer services may not directly improve survival
Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study.
No full textAbstract
We used data supplied by population-based cancer registries, collected and quality controlled using a common protocol, to analyse survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) among children in 17 European countries. Variations in survival in relation to age, country, histologic subtype and period of diagnosis (1978--1992) were examined. These are rare malignancies and survival can be studied reliably only by examination of data from a very large population (in this case EUROCARE). 5 years after diagnosis, overall survival was 44% (95% CI 33--55) for CML and 37% (95% CI 32--43) for ANLL. For both types of leukaemia, survival was slightly better for girls and worse in children under 5 years of age. Consistent with clinical literature, the ANLL subtypes with poorer prognosis were monocytic, megakaryocytic and erythroleukaemia. For ANLL, 5-year survival was better in Finland, the UK, The Netherlands and Germany (> or =40%); for CML, 5-year survival was highest in Italy, although the 95% CI were wide. The risk of death from ANLL and CML fell by 7% per year and 5% per year, respectively, after adjustment for age, gender and country. Since these rare childhood malignancies were virtually untreatable until 1970, these are very welcome trends
- …
